Literature DB >> 33629230

How to Predict Postoperative Complications After Early Laparoscopic Cholecystectomy for Acute Cholecystitis: the Chole-Risk Score.

Marcello Di Martino1, Ismael Mora-Guzmán2,3, Víctor Vaello Jodra4, Alfonso Sanjuanbenito Dehesa4, Dieter Morales García5, Rubén Caiña Ruiz5, Francisca García-Moreno Nisa6, Fernando Mendoza Moreno6, Sara Alonso Batanero7, José Edecio Quiñones Sampedro7, Paola Lora Cumplido8, Altea Arango Bravo6, Ines Rubio-Perez9, Luis Asensio-Gomez9, Fernando Pardo Aranda10, Sara Sentí Farrarons10, Cristina Ruiz Moreno11, Clara Maria Martinez Moreno11, Aingeru Sarriugarte Lasarte12, Mikel Prieto Calvo12, Daniel Aparicio-Sánchez13, Eduardo Perea Del Pozo13, Gianluca Pellino14,15, Elena Martin-Perez2.   

Abstract

BACKGROUND: Early laparoscopic cholecystectomy (ELC) is the gold standard treatment for patients with acute calculous cholecystitis (ACC); however, it is still related to significant postoperative complications. The aim of this study is to identify factors associated with an increased risk of postoperative complications and develop a preoperative score able to predict them.
METHODS: Multicentric retrospective analysis of 1868 patients with ACC submitted to ELC. Included patients were divided into two groups according to the presentation of increased postoperative complications defined as postoperative complications ≥ Clavien-Dindo IIIa, length of stay greater than 10 days and readmissions within 30 days of discharge. Variables that were independently predictive of increased postoperative complications were combined determining the Chole-Risk Score, which was validated through a correlation analysis.
RESULTS: We included 282 (15.1%) patients with postoperative complications. The multivariate analysis predictors of increased morbidity were previous percutaneous cholecystostomy (OR 2.95, p=0.001), previous abdominal surgery (OR 1.57, p=0.031) and diabetes (OR 1.62, p=0.005); Charlson Comorbidity Index >6 (OR 2.48, p=0.003), increased total bilirubin > 2 mg/dL (OR 1.88, p=0.002), dilated bile duct (OR 1.79, p=0.027), perforated gallbladder (OR 2.62, p<0.001) and severity grade (OR 1.93, p=0.001). The Chole-Risk Score was generated by grouping these variables into four categories, with scores ranging from 0 to 4. It presented a progressive increase in postoperative complications ranging from 5.8% of patients scoring 0 to 47.8% of patients scoring 4 (p<0.001).
CONCLUSION: The Chole-Risk Score represents an intuitive tool capable of predicting postoperative complications in patients with ACC.

Entities:  

Keywords:  cholecystectomy; cholecystitis; early laparoscopic cholecystectomy; postoperative complication

Year:  2021        PMID: 33629230     DOI: 10.1007/s11605-021-04956-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  2 in total

1.  Consistency of ASA grading.

Authors:  J P Little
Journal:  Anaesthesia       Date:  1995-07       Impact factor: 6.955

Review 2.  An analysis of the problem of biliary injury during laparoscopic cholecystectomy.

Authors:  S M Strasberg; M Hertl; N J Soper
Journal:  J Am Coll Surg       Date:  1995-01       Impact factor: 6.113

  2 in total
  2 in total

1.  Percutaneous Cholecystostomy for Acute Cholecystitis: A Three-Year Single-Centre Experience Including During COVID-19.

Authors:  Taner Shakir; Kabir Matwala; Abhilash Vasan; Stavros Karamanakos
Journal:  Cureus       Date:  2021-12-13

2.  Early laparoscopic cholecystectomy in oldest-old patients: a propensity score matched analysis of a nationwide registry.

Authors:  Marcello Di Martino; Álvaro Gancedo Quintana; Víctor Vaello Jodra; Alfonso Sanjuanbenito Dehesa; Dieter Morales García; Rubén Caiña Ruiz; Francisca García-Moreno Nisa; Fernando Mendoza-Moreno; Sara Alonso Batanero; José Edecio Quiñones Sampedro; Paola Lora Cumplido; Altea Arango Bravo; Ines Rubio-Perez; Luis Asensio-Gomez; Fernando Pardo Aranda; Sara Sentí Farrarons; Cristina Ruiz Moreno; Clara Maria Martinez Moreno; Aingeru Sarriugarte Lasarte; Mikel Prieto Calvo; Daniel Aparicio-Sánchez; Eduardo Perea Perea Del Pozo; Gianluca Pellino; Elena Martin-Perez
Journal:  Updates Surg       Date:  2022-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.